Connection between self-stigma, adherence to treatment, and discontinuation of medication
Status PubMed-not-MEDLINE Jazyk angličtina Země Nový Zéland Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
27524884
PubMed Central
PMC4966500
DOI
10.2147/ppa.s99136
PII: ppa-10-1289
Knihovny.cz E-zdroje
- Klíčová slova
- adherence, discontinuation of drugs, mental disorders, self-stigma,
- Publikační typ
- časopisecké články MeSH
INTRODUCTION: Self-stigma plays a role in many areas of the patient's life. Furthermore, it also discourages therapy. The aim of our study was to examine associations between self-stigma and adherence to treatment and discontinuation of medication in patients from various diagnostic groups. METHODS: This cross-sectional study involved outpatients attending the Department of Psychiatry, University Hospital Olomouc, Czech Republic. The level of self-stigma was measured with the Internalized Stigma of Mental Illness and adherence with the Drug Attitude Inventory. The patients also anonymously filled out a demographic questionnaire which included a question asking whether they had discontinued their medication in the past. RESULTS: We examined data from 332 patients from six basic diagnostic categories (substance abuse disorders, schizophrenia, bipolar disorders, depressive disorders, anxiety disorders, and personality disorders). The study showed a statistically significant negative correlation between self-stigma and adherence to treatment in all diagnostic groups. Self-stigma correlated positively and adherence negatively with the severity of disorders. Another important factor affecting both variables was partnership. Self-stigma positively correlated with doses of antidepressants and adherence with doses of anxiolytics. Self-stigma also negatively correlated with education, and positively with a number of hospitalizations and number of psychiatrists visited. Adherence was further positively correlated with age and age of onset of disorders. Regression analysis showed that self-stigma was an important factor negatively influencing adherence to treatment and significantly contributing to voluntary discontinuation of drugs. The level of self-stigma did not differ between diagnostic categories. Patients suffering from schizophrenia had the lowest adherence to treatment. CONCLUSION: The study showed a significant correlation between self-stigma and adherence to treatment. High levels of self-stigma are associated with discontinuation of medications without a psychiatrist's recommendation. This connection was present in all diagnostic groups.
Department of Psychiatry University Hospital Olomouc
Faculty of Medicine and Dentistry Palacky University Olomouc Olomouc Czech Republic
Zobrazit více v PubMed
Link BG, Phelan JC, Bresnahan M, Stueve A, Pescosolido BA. Public conceptions of mental illness: Labels, causes, dangerousness, and social distance. Am J Public Health. 1999;89(9):1328–1333. PubMed PMC
Corrigan PW, Rafacz J, Rüsch N. Examining a progressive model of self-stigma and its impact on people with serious mental illness. Psychiatry Res. 2011;189(3):339–343. PubMed PMC
Barney LJ, Griffiths KM, Christensen H, Jorm AF. Exploring the nature of stigmatising beliefs about depression and help-seeking: implications for reducing stigma. BMC Public Health. 2009;9:61. PubMed PMC
Rüsch N, Angermeyer MC, Corrigan PW. Mental illness stigma: concepts, consequences, and initiatives to reduce stigma. Eur Psychiatry. 2005;20(8):529–539. PubMed
Livingston JD, Boyd JE. Correlates and consequences of internalized stigma for people living with mental illness: a systematic review and meta-analysis. Soc Sci Med. 2010;71:2150–2161. PubMed
Ritsher JB, Phelan JC. Internalized stigma predicts erosion of morale among psychiatric outpatients. Psychiatry Res. 2004;129(3):257–265. PubMed
Ocisková M, Praško J, Látalová K, et al. Internalizované stigma a efektivita farmakoterapie a psychoterapie u úzkostných poruch a poruch neurotického spektra. [Internalized stigma and efficacy of pharmacotherapy and psychotherapy in anxiety disorders and neurotic spectrum disorders] Česká a Slovenská Psychiatrie. 2014b;110(3):133–143.
Raboch J, Uhliková P, Hellerová P, Anders M, Šusta M. Psychiatrie: Doporučené postupy v psychiatrické péče. [Psychiatry: Treatment guidelines] Psychiatrická společnost] ČLS JEP;
World Health Organization (WHO) ICD-10: The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: Word Health Organization; 1992.
Boyd JE, Adler EP, Otilingam PG, Peters T. Internalized Stigma of Mental Illness (ISMI) scale: A multinational review. Compr Psychiatry. 2014;55(1):221–231. PubMed
Ritsher JB, Otilingam PO, Grajales M. Internalized stigma of mental illness: psychometric properties of a new measure. Psychiatry Res. 2003;121:31–49. PubMed
Lysaker PH, Roe D, Yanos PT. Toward understanding the insight paradox: Internalized stigma moderates the association between insight and social functioning, hope, and self-esteem among people with schizophrenia spectrum disorders. Schizophr Bull. 2007;33(1):192–199. PubMed PMC
Ociskova M, Prasko J, Dostalova L, et al. Self-stigma in psychiatric patients – standardization of the ISMI scale. Neuro Endocrinol Lett. 2014;35(7):624–632. PubMed
Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med. 1983;13(1):177–183. PubMed
Guy W, editor. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: U.S. DHEW; 1976.
EMEA 2002. [Accessed March 20, 2009]. Available from: http://www.ema.europa.eu/pdfs/human/ich/013595en.pdf.
Tsang HW, Fung KM, Chung RC. Self-stigma and stages of change as predictors of treatment adherence of individuals with schizophrenia. Psychiatry Res. 2010;180(1):10–15. PubMed
Fung KM, Tsang HW, Chan F. Self-stigma, stages of change and psychosocial treatment adherence among Chinese people with schizophrenia: a path analysis. Soc Psychiatry Psychiatr Epidemiol. 2010;45(5):561–568. PubMed
Lyimo RA, Stutterheim SE, Hospers HJ, de Glee T, van der Ven A, de Bruin M. Stigma, disclosure, coping, and medication adherence among people living with HIV/AIDS in Northern Tanzania. AIDS Patient Care STDS. 2014;28(2):98–105. PubMed
Sirey JA, Bruce ML, Alexopoulos GS, et al. Perceived stigma as a predictor of treatment discontinuation in young and older outpatients with depression. Am J Psychiatry. 2001;158:479–481. PubMed
Sirey JA, Bruce ML, Alexopoulos GS, Perlick DA, Friedman SJ, Meyers BS. Stigma as a barrier to recovery: Perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatr Serv. 2001;52(12):1615–1620. PubMed
Sirey JA, Bruce ML, Alexopoulos GS, et al. Perceived stigma as a predictor of treatment discontinuation in young and older outpatients with depression. Am J Psychiatry. 2001;158(3):479–481. PubMed
Sirey JA, Bruce ML, Alexopoulos GS. The treatment initiation program: an intervention to improve depression outcomes in older adults. Am J Psychiatry. 2005;162(1):184–186. PubMed
DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200–209. PubMed
DiMatteo RM, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment. Arch Intern Med. 2000;160:2101–2107. PubMed
Blouin A, Perez E, Minoletti A. Compliance to referrals from the psychiatric emergency room. Can J Psychiatry. 1985;30:103–106. PubMed
Kalichman SC, Ramachandran B, Catz S. Adherence to combination antiretroviral therapies in HIV patients of low health literacy. J Gen Intern Med. 1999;14(5):267–273. PubMed PMC
Last CG, Thase ME, Hersen M, Bellack AS, Himmelhoch JM. Patterns of attrition for psychosocial and pharmacologic treatments of depression. J Clin Psychiatry. 1984;46:361–366. PubMed
Power R, Koopman C, Volk J, et al. Social support, substance use, and denial in relationship to antiretroviral treatment adherence among HIV-infected persons. AIDS Patient Care. 2003;17(5):245–252. PubMed
Matas M, Staley D, Griffin W. A profile of the noncompliant patient: a thirty-month review of outpatient psychiatry referrals. Gen Hosp Psychiatry. 1992;14:124–130. PubMed
Melfi CA, Chawla AJ, Croghan TW, Hanna MP, Kennedy S, Sredl K. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatry. 1998;55(12):1128–1132. PubMed
Lingam R, Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr Scand. 2002;105(3):164–172. PubMed
Babiker IE. Noncompliance in schizophrenia. Psychiatr Dev. 1986;4:329–337. PubMed
Gilmer TP, Dolder CR, Lacro JP, et al. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Am J Psychiatry. 2004;161:692–699. PubMed
Bulloch AGM, Patten SB. Non-adherence with psychotropic medications in the general population. Soc Psychiatry Psychiatr Epidemiol. 2010;45(1):47–56. PubMed
Brohan E, Elgie R, Sartorius N, Thornicroft G. Self-stigma, empowerment and perceived discrimination among people with schizophrenia in 14 European countries: The GAMIAN-Europe study. Schizophrenia Res. 2010;122(1–3):232–238. PubMed
Girma E, Tesfaye M, Froeschl G, Möller-Leimkühler AM, Dehning S, Müller N. Facility based cross-sectional study of self stigma among people with mental illness: towards patient empowerment approach. Int J Ment Health Syst. 2013;7(1):21. PubMed PMC
Yen CF, Chen CC, Lee Y, Tang TC, Yen JY, Ko CH. Self-stigma and its correlates among outpatients with depressive disorders. Psychiatr Serv. 2005;56(5):599–601. PubMed
Ustündağ MF, Kesebir S. Internalized stigmatization in bipolar patients: relationship with clinical properties, quality of life and treatment compliance. Turk Psikiyatri Derg. 2013;24(4):231–239. PubMed
Temilola MJ, Adegoke AO, Olaolu AT, Adegboyega O, Olaide AK. Self-stigma, quality of life and schizophrenia: An outpatient clinic survey in Nigeria. Int J Soc Psychiatry. 2014;60(4):377–386. PubMed
Werner P, Stein-Shvachman I, Heinik J. Perceptions of self-stigma and its correlates among older adults with depression: A preliminary study. Int Psychogeriatr. 2009;21(6):1180–1189. PubMed
Lv Y, Wolf A, Wang X. Experienced stigma and self-stigma in Chinese patients with schizophrenia. Gen Hosp Psychiatry. 2013;35(1):83–88. PubMed
Fung KMT, Tsang HWH, Corrigan PW. Self-stigma of people with schizophrenia as predictor of their adherence to psychosocial treatment. Psychiatr Rehabil J. 2008;32:485–495. PubMed
Tsang HW, Fung KM, Chung RC. Self-stigma and stages of change as predictors of treatment adherence of individuals with schizophrenia. Psychiatry Res. 2010;180(1):10–15. PubMed
Kranke DA, Floersch J, Kranke BO, Munson MR. A qualitative investigation of self-stigma among adolescents taking psychiatric medication. Psychiatr Serv. 2011;62(8):893–899. PubMed
Correlates of Negative Attitudes towards Medication in People with Schizophrenia
Self-stigma and treatment effectiveness in patients with anxiety disorders - a mediation analysis
Quality of life, self-stigma, and hope in schizophrenia spectrum disorders: a cross-sectional study
Self-stigma and schizophrenia: a cross-sectional study
Self-stigma and quality of life in patients with depressive disorder: a cross-sectional study